Patent: 7,411,050
✉ Email this page to a colleague
Summary for Patent: 7,411,050
Title: | Monoclonal blocking antibody to human RANKL |
Abstract: | Disclosed herein are kits for detecting RANKL protein or nucleic acids, the kits comprising isolated human RANKL polypeptides, RANKL nucleic acids and/or antibodies specific for RANKL. |
Inventor(s): | Anderson; Dirk M. (Seattle, WA) |
Assignee: | Immunex Corporation (Thousand Oaks, CA) |
Application Number: | 10/802,133 |
Patent Claims: | see list of patent claims |
Details for Patent 7,411,050
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 06/01/2010 | ⤷ Try a Trial | 2016-12-23 |
Amgen, Inc. | XGEVA | denosumab | Injection | 125320 | 11/18/2010 | ⤷ Try a Trial | 2016-12-23 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,411,050
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 401404 | ⤷ Try a Trial |
Austria | 412746 | ⤷ Try a Trial |
Austria | 497001 | ⤷ Try a Trial |
Austria | 517916 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |